5.5 en Immune Response-2014
-
Upload
alberto-mayorga -
Category
Documents
-
view
213 -
download
0
Transcript of 5.5 en Immune Response-2014
-
8/19/2019 5.5 en Immune Response-2014
1/50
IMMUNE RESPONSE
BiochemistryLecture 5.5
Prof. Dalė Vieželienė
Department of Biochemistry
E-mail: [email protected]
-
8/19/2019 5.5 en Immune Response-2014
2/50
• Uses two basic strategies
Humoral Immunity
- works to eliminate antigens that are extracellular
Cellular Immunity
- deals with antigens within host cell
OVERVIEW OF ADAPTIVE IMMUNITY
-
8/19/2019 5.5 en Immune Response-2014
3/50
Humoral
Immunity
-
8/19/2019 5.5 en Immune Response-2014
4/50
IMMUNOGLOBULINS Ig
(ANTIBODIES)
Glycoprotein molecules that are produced by plasma cells in
response to an immunogen and which function as antibodies
Receptors for antigen on B-cells When secreted – immunoglobulin (antibodies)
One B-cell makes only one kind of antibody
Immunoglobulins comprise approx. 20 % proteins of blood
plasma
-
8/19/2019 5.5 en Immune Response-2014
5/50
• Antigen - any structure which el ici ts an immuneresponse
• Recognition is a central feature of the immuneresponse, required for detection and elimination ofdangerous organisms (pathogens)
• This recognition is mediated by specific antigenreceptors which bind to structures (antigens) on, orderived from, pathogens.
• Antigen receptors can be secreted or cell-associated
Antigen recognition is mediated
by specific antigen receptors
-
8/19/2019 5.5 en Immune Response-2014
6/50
Antigenic determinant (epitope)
-
8/19/2019 5.5 en Immune Response-2014
7/50
Structure of Immunoglobulins
•2 identical Light chainsκ or λ – each about 220
amino acids
•2 identical Heavy chains -a d e g
or m -
each about
450 amino acids
2 λ + 2γ
•Disulfide bonds:• Inter-chain
• Intra-chain
•
Oligosaccharides
CH1
VL
CL
VH
CH2 CH3
Hinge Region
Carbohydrate
Disulfide bond
•Variable & Constant Regions
VL & CL
VH & CH
• Hinge Region
•Domains (Domains are folded,compact, protease resistant
structures)
VL & CLVH & CH1 - CH3 (or CH4)
-
8/19/2019 5.5 en Immune Response-2014
8/50
A typical antibody molecule
CHO CHO
•Fab - fragment
antigen binding
•Fc - fragment
crystallisable
Fc – effector
functions. Fc
interacts with
innate effector
mechanisms and
greatly amplifiesthem
Carbo-
hydrate
Fab
Fc
Immunoglobulins are
Bifunctional Proteins
-
8/19/2019 5.5 en Immune Response-2014
9/50
Pepsin cleavage sites - 1 x (Fab)2 & 1 x Fc
Papain cleavage sites - 2 x Fab 1 x Fc
-
8/19/2019 5.5 en Immune Response-2014
10/50
Antigens can bind in
pockets or grooves or on
extended surfaces in the
binding site of antibodies
by non-covalent forces
-
8/19/2019 5.5 en Immune Response-2014
11/50
-
8/19/2019 5.5 en Immune Response-2014
12/50
Why do antibodies need an Fc region?
• Detect antigen
• Precipitate antigen
• Block the active sites of toxins or pathogen-associated
molecules
• Block interactions between host and pathogen-associated
molecules
The (Fab)2
fragment can:
• Inflammatory and effector functions associated with cells
• Inflammatory and effector functions of complement
• The trafficking of antigens into the antigen processing
pathways
The Fc fragment can activate:
-
8/19/2019 5.5 en Immune Response-2014
13/50
Consequences of antibody-antigen
binding
A. Viral Inhibition: virus preventing it from attaching to cellB. Neutralization: make toxins unable to bind to cellsC. Opsonization: antibodies bind to antigen and facilitate
attachment of phagocytic cells
D. and E. Agglutination and Precipitation: antibodies bind toantigen and get them into clumps, then one big “mouthful”for phagocyte
F. Phagocytosis: Fc portion of antibody encouragesphagocytosis
Complement Activation: binding of antigen to antibody cantrigger one pathway of complement cascade
-
8/19/2019 5.5 en Immune Response-2014
14/50
-
8/19/2019 5.5 en Immune Response-2014
15/50
The complement system
Interacting set of enzymes (proteases) that upon activation giverise to cascade of reactions culminating in the destruction of
pathogens and infected cells
-
8/19/2019 5.5 en Immune Response-2014
16/50
-
8/19/2019 5.5 en Immune Response-2014
17/50
Classes of immunoglobulins
(depend on H chain)
-
8/19/2019 5.5 en Immune Response-2014
18/50
• Classes: IgM, IgG, IgD, IgA, IgE
• Subclasses - IgG1, IgG2, IgG3, IgG4
ANTIBODY CLASSES AND SUBCLASSES
(ISOTYPES)
MONOMER PENTAMER MONOMER DIMER MONOMER
MONOMER WHEN
ACTING AS B-CELL
RECEPTOR FOR ANTIGEN
-
8/19/2019 5.5 en Immune Response-2014
19/50
IgG
(Monomeric)
– Major serum Ig
– Major Ig in extravascular spaces – 70-80% of total serum
antibody
– Half-life in serum – 23 days
– Placental transfer (IgG2) – Fixes complement (IgG4)
– Binds to Fc receptors (IgG2, IgG4)
• Phagocytes - opsonization
IgG1, IgG2 and IgG4 IgG3
-
8/19/2019 5.5 en Immune Response-2014
20/50
The pentameric IgM molecule
irst line of defence
Extra domain (CH4)J chain
First Ig made by fetus and B cells
5-10% of total serum antibody
Half-life in serum – 5 days
Fixes complement
Agglutinating Ig
Binds to Fc receptors
B cell surface Ig
-
8/19/2019 5.5 en Immune Response-2014
21/50
Dimeric IgA- protection of the mucosa
•Serum – monomer
•Secretions (sIgA) - major secretory Ig (Mucosal or Local Immunity)
•10-15 % of total serum antibody (if mucous membranes and body secretions
included, percentage is much higher)•Half-life in serum – 6 days
Tears, saliva, gastric and pulmonary secretions
Dimer: J chain; Secretory component
Does not fix complement (unless aggregated)
Binds to Fc receptors on some cells
-
8/19/2019 5.5 en Immune Response-2014
22/50
IgD (Monomer)
– 0,2% of total serum antibody
– Half-life in serum – 3 days
– B cell surface Ig, blood, lymph
– Does not bind complement, serum function
not known
I l b li St t
-
8/19/2019 5.5 en Immune Response-2014
23/50
•Secreted antibody
Neutralisation
Arming/recruiting effector cells
Complement fixation
• Cell surface antigen receptor on B cells
Allows B cells to sense their antigenic
environment
Connects extracellular space with intracellular
signalling machinery
Immunoglobulin Structure-
Function Relationship
-
8/19/2019 5.5 en Immune Response-2014
24/50
IgE (Monomer)
– Extra domain CH4
– Least common serum Ig
– 0,002% of total serum antibody
– Half-life in serum – 2 days
• Binds to basophils and mast cells
– Allergic reactions – Parasitic infections (Helminths)
• Binds to Fc receptor on eosinophils
– Does not fix complement
-
8/19/2019 5.5 en Immune Response-2014
25/50
Diversity: Antibody diversity is
generated by:
Multiple genes encoding both VL and VH
Segmental joining of additional DNA segments to form the
mature VL and VH genes
Addition of nucleotide bases during the joining event
Random association of Heavy and Light chains (facilitated by
the VC, CH1 disulfide bond)
Somatic (body) mutation of mature heavy and light chain
genes after antigen stimulation generate higher affinity
antibodies
-
8/19/2019 5.5 en Immune Response-2014
26/50
Variable domains in immunoglobulins are made
by combinatorial joining of gene segments
-
8/19/2019 5.5 en Immune Response-2014
27/50
-
8/19/2019 5.5 en Immune Response-2014
28/50
Immunoglobulins and Development:
Fetal synthesis of IgM and IgA begin during the 5th month.
Immature B-cells express IgM on surface. IgM is monomeric on
surface.
Mature B-cells express IgM and IgD on surface.
Plasma cells can secrete IgM, IgG, IgA, IgE (all but IgD)
Memory cells display IgG, IgA, IgE, alone or combined with
IgM. These are usually higher affinity than the orginal B-cell
clone because of affinity maturation via somatic cell mutation
Th i l b li f il f
-
8/19/2019 5.5 en Immune Response-2014
29/50
The immunoglobulin superfamily of
proteins
• Variety of other proteinswhich exhibit amino acid
sequence homology with Ig
also contain Ig-like domains
and are considered as
members of the
immunoglobulin superfamily
• The genes that encode these
proteins have evolved from a
common ancestor gene coding
for a single domain.
• The structural hallmark of
immunoglobulin structure is the
existence of globular „domains with
β-pleated sheet folding pattern.
-
8/19/2019 5.5 en Immune Response-2014
30/50
The immunoglobulin superfamily of proteins
-
8/19/2019 5.5 en Immune Response-2014
31/50
B Cell Antigen Receptor (BCR)
Ig-β Ig-α Ig-α Ig-β
-
8/19/2019 5.5 en Immune Response-2014
32/50
-
8/19/2019 5.5 en Immune Response-2014
33/50
B-cells and Antibody Response
• B-cell receptor binds to antigen
• One of two things happen:
– B-cell needs confirmation by T-cell to begin
responding
– B-cell does not need confirmation by T-cell to
begin responding
-
8/19/2019 5.5 en Immune Response-2014
34/50
When B-cell does not need
confirmation from T-cell• B-cell receptors bind epitopes
• B-cells respond by proliferating, producing
antibody and differentiating into memory B-cells
-
8/19/2019 5.5 en Immune Response-2014
35/50
When B-cell needs confirmation from T-cell
-
8/19/2019 5.5 en Immune Response-2014
36/50
-
8/19/2019 5.5 en Immune Response-2014
37/50
CELLULAR IMMUNITY
Types of T cells (cellular immune
-
8/19/2019 5.5 en Immune Response-2014
38/50
Types of T cells (cellular immune
response)
• Also called CD8 T cells
• Once activated, induce apoptosis in
“self” cells infected with virus; destroy
cancerous host cells
• Distinguish infected “self” cells, because
these cells present peptides on surface in
MHC class I molecule
• Also called CD4 T-cells
• Antigen presenting cells, present
antigen to T-helper cells in MHCclass II
• If recognize antigen presented as
foreign, activate macrophages,
release cytokines that recruit other
cells of immune system, stimulate NK cells activate B cells
T Cell Receptor (TCR)
-
8/19/2019 5.5 en Immune Response-2014
39/50
TcR molecule resembles Fab and is monovalent
T Cell Receptor (TCR)
The TCRs are
transmembrane,
insoluble proteins.
Approximately 105
TcR molecules arepresent on the surface
of a T cell.
•Consists of an α and
β chain, or a γ and δ
chain.
• In human majority of T cells express the αβ heterodimer;
the remaining T cells (small percentage) express the γδ
heterodimer (no αδ, or γβ T cells exist).
• Each chain has a variable (V) and a constant domain (C).
TCR Structure
-
8/19/2019 5.5 en Immune Response-2014
40/50
TCR Structure
•The variable domains in both chains contain threehypervariable regions which are equivalent to CDRs present in
Ab light and heavy chains.
• Transmembrane domains of both chains contain positively
charged amino acid residues
• The most αβ TCRs interact with peptide antigens presented by
MHC molecules.
• Certain αβ T cells react with nonpeptide antigens
(carbohydrate and lipids)
• In contrast to αβ TCR, γδ TCR exhibits limited diversity • The γδ T cells react with antigen (e.g. phospholipid antigen of
Mycobacter ium tuberculosis ) that is neither processed or
presented in the context of a MHC molecule.
-
8/19/2019 5.5 en Immune Response-2014
41/50
TCR αβ chain receptor gene
rearrange similar to antibody genes
-
8/19/2019 5.5 en Immune Response-2014
42/50
C i f TCR d BCR
-
8/19/2019 5.5 en Immune Response-2014
43/50
Comparison of TCR and BCR
(antibody)
BCR TCR
Ligand Any structure peptide & lipid
Bind native ligand Yes No
Ag processing No Yes
MHC restriction No Yes
Somatic mutation Yes No
Affinity for ligand Low to very high Low
Co-receptors No Yes
T ll i th ti l h it i
-
8/19/2019 5.5 en Immune Response-2014
44/50
• T cells recognize the antigen only when it is
presented by self-MHC molecule.
•This phenomenon, called self -MHC
restriction, differentiates recognition of
antigen by T cells and B cells.The MHC is highly polymorphic from individual
to individual
Single receptorrecognizes
an alteration in self-
MHC molecules induced
because of association
with foreign antigen.
-
8/19/2019 5.5 en Immune Response-2014
45/50
-
8/19/2019 5.5 en Immune Response-2014
46/50
-
8/19/2019 5.5 en Immune Response-2014
47/50
Class I molecules are expressed on the surfaces of virtually all
nucleated cells at varying densities
Class II molecules are more restricted to cells of the immune
system, primarily B lymphocytes and monocytes.
Class I molecules function at the effector phase of immunity by
presenting antigens to CD8+ T cells, which generally have cytotoxic
or suppressor function Class II molecules present antigenic fragments to the CD4+ inducer
(or helper) T cells on antigen presenting cells such as macrophages
MHC class I molecules present peptides derived from cytosolic
proteins; the pathway is called the cytosolic or endogenous pathway
MHC class II molecules present peptides derived from extracellular
proteins; the pathway is called the endocytic or exogenous pathway.
-
8/19/2019 5.5 en Immune Response-2014
48/50
Epitopes recognized by TCR does not
need to lie on the surface of the protein
-
8/19/2019 5.5 en Immune Response-2014
49/50
-
8/19/2019 5.5 en Immune Response-2014
50/50
Interplay between T-cells and B-cells